FFT Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
FFT Wealth Management's BMY Position: Q4 2021 in Review
FFT Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 3,406 shares — an estimated $202K sold.
FFT Wealth Management first reported a position in BMY in Q2 2021 and held it in 2 quarters. The position peaked at $224K in Q2 2021. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.
- FFT Wealth Management reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
- FFT Wealth Management sold 3,406 Bristol-Myers Squibb shares in Q4 2021, an estimated $202K.
- FFT Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2021 and held it in 2 quarters.
- FFT Wealth Management's Bristol-Myers Squibb position peaked at $224K in Q2 2021.
- 2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.
Based on FFT Wealth Management's 13F filing for Q4 2021, filed 14 Feb 2022.